Epizódjegyzetek
This episode of Behavior and Risk examines how AI is being deployed across healthcare—from chatbots and personalized treatment planning to imaging and surgical tools—and focuses on the regulatory landscape, especially in the United States. We argue U.S. oversight is a patchwork that relies heavily on the FDA’s “substantial equivalence” pathway (97% of authorizations), a framework rooted in older standards, while AI systems function as black boxes and evolve rapidly. We discuss information asymmetry between developers and regulators, FDA staffing losses, and how incentives and cognitive…
Weboldal: podcasters.spotify.com

